Showing results (251-260 of 4,786) with videos related to
Sort By:
Pageof 479
Brain Sciences|February 26, 2025
Eye-Tracking Metrics as a Digital Biomarker for Neurocognitive Disorders in Multiple Sclerosis: A Scoping ReviewSonja Cecchetti, Andrew T Duchowski, Marco CavalloJournal of Integrative Neuroscience|May 30, 2026
"See What I Mean?" Linguistic Digital Markers of Cognitive Decline in Nursing Home ResidentsSonja Cecchetti, Andrew T Duchowski, Marco CavalloTopics in Current Chemistry|February 4, 2011
N-heterocyclic carbene complexes of au, pd, and pt as effective catalysts in organic synthesisAndrea Correa, Steven P Nolan, Luigi CavalloPathologie-Biologie|June 1, 1997
[Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study]P Dubrous, J D Cavallo, Y BuissonNature Reviews. Cancer|August 19, 2007
Are oncoantigens suitable targets for anti-tumour therapy?Federica Cavallo, Raffaele Adolfo Calogero, Guido ForniAnnals of Work Exposures and Health|April 17, 2020
COVID-19 Outbreak in Italy: Protecting Worker Health and the Response of the Italian Industrial Hygienists AssociationAndrea Spinazzè, Andrea Cattaneo, Domenico M CavalloThe Journal of Organic Chemistry|February 26, 2005
Regio- and stereoselective ring opening of 2,3-diaryl oxiranes by LiBr/Amberlyst 15: a new stereocontrolled access to 1,2-diaryl-2-bromo alcoholsArlette Solladié-Cavallo, Paolo Lupattelli, Carlo BoniniPathologie-Biologie|April 1, 1995
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood]B Chevalier, J D Cavallo, M MeyranLa Medicina Del Lavoro|July 16, 2009
[Improvement of a sedimentation method for measuring dispersion of fibres from asbestos cement roofs]A Cattaneo, D M Cavallo, G ChiappinoDrug Development Research|August 30, 2016
Benefits of Cognitive Treatments Administered to Patients Affected by Mild Cognitive Impairment/Mild Neurocognitive DisorderMarco Cavallo, Arianna Signorino, Maria Luisa PerucchiniPageof 479